twitterfacebook Change Font Size

Baker, Jason V., MD

Member, Medicine and Infectious Diseases

Clinic(s)

HCMC Infectious Disease Clinic

612-873-2700
612-904-4440

HCMC Positive Care Center

612-873-2700
612-904-4440

Medical School:

University of Wisconsin Madison, Madison, WI, USA

Other Specialty Location(s):

Medicine - Infectious Diseases

Additional Information:

Jason V Baker, M.D., M.S., is an assistant professor of medicine in the division of I.D.I.M. and staff physician at HCMC. His clinical practice includes HIV medicine and inpatient general infectious disease consultation. He is conducting clinical research on cardiovascular and other common end-organ complications in persons with HIV infection, with emphasis on the mechanisms and disease risk related to vascular damage.

Dr. Bakers post-secondary education began at the University of Wisconsin (Madison) where he earned a B.S. (1996). He continued on at UW for medical school (1997-2001), before moving to Portland, OR for his Internal Medicine training (2001-2004) at Oregon Health & Science University (OHSU). He then completed a clinical and research fellowship in infectious diseases and international medicine at the University of Minnesota, where he also earned a Masters degree in clinical research. During fellowship he initially conducted HIV pathogenesis research with Dr. Schackers group, and later focused on clinical trial projects with Drs. Jim Neaton and Keith Henry.

Dr. Bakers research is currently funded through a U of Minn NIH K12 award. He is collaborating with Drs. Jim Neaton, Keith Henry, Daniel Duprez and Richard Grimm of the U of MN. In addition to ongoing projects at the HCMC HIV clinic (Positive Care Center), he collaborates with the CDC sponsored SUN study (Study to Understand the Natural history of HIV/AIDS in the era of effective therapy) examining long-term complications resulting from HIV infection and anti-retroviral therapy. Dr. Baker also works with the INSIGHT network (International Network for Strategic Initiatives in Global HIV Trials) on multi-center HIV treatment studies. He serves as a co-convener of the INSIGHT cardiovascular interest group and is collaborating on the cardiovascular sub-study of the START (Strategic Timing of Anti-Retroviral Therapy) trial.

Joint Commission Seal